Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Sittings . . . . PDF . . . . Video

Legislative Assembly for the ACT: 2021 Week 13 Hansard (Tuesday, 30 November 2021) . . Page.. 3816 ..


If passed unamended, I am concerned that the government bill will not meet its stated aim of improving road safety and strengthening the regulatory and enforcement framework. I have presented detailed reasons in my tabled dissenting report. I otherwise support the committee recommendations. I note my appreciation for the cooperative and constructive work of this committee, particularly our very hardworking committee secretariat, and the work of my colleagues Ms Orr and Mr Parton.

Question resolved in the affirmative.

Drugs of Dependence (Personal Use) Amendment Bill 2021—Select Committee

Report

MR CAIN (Ginninderra) (10.24): I present the following report:

Drugs of Dependence (Personal Use) Amendment Bill 2021—Select Committee—Report—Inquiry into the Drugs of Dependence (Personal Use) Amendment Bill 2021, dated 25 November 2021, including a dissenting report (Mr Cain), together with a copy of the relevant minutes of proceedings.

I move:

That the report be noted.

I clarify that I speak not as chair of this committee but as a committee member and as a member for the electorate of Ginninderra.

I was very pleased to be a part of this committee process that inquired into this very significant piece of legislation. It should be noted—and it will be fairly obvious from the published report—that I dissent from the recommendations that support the passage of the bill.

I also provide amendments to recommendations that touch on the implementation of the bill as if it were, indeed, passed. Instead, I focus my attention on the changes made to the Drugs of Dependence Act by way of the Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019.

I agree with the majority of recommendations in the report, in particular 7 to 16, which relate to improving and better resourcing the drug support sector and advancing harm minimisation policies and practices. The only exception is that, given my dissent from supporting the bill, the fourth point in recommendation 16 is redundant.

I also agree with the content of chapters 1 and 3 of the committee report—background and the services sector respectively—except with regard to recommendations from which I have indicated my dissent, or those that I would amend.

In my dissenting report I present the reasons why I believe that the Drugs of Dependence (Personal Use) Amendment Bill 2021 should not be passed. I will make some general comments before I move to my substantive arguments.


Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Sittings . . . . PDF . . . . Video